MedPath

Glycocalyx and Microcirculation in Sepsis

Completed
Conditions
Sepsis
Registration Number
NCT03960307
Lead Sponsor
University Hospital Muenster
Brief Summary

The aim of this observative, prospective study with cross-sectional design is to explore possible correlations/associations between microcirculation parameters and sublingual endothelial glycocalyx in sepsis. Therefore, 30 critically ill septic patients and 10 healthy controls were enrolled.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlations between Perfused Boundary Region (PBR) and Proportion of Perfused Vessels (PPV) measured sublinguallyDuring ICU stay, an average of 2 days after sepsis onset

Glycocalyx thickness will be measured with PBR (in μm) and PPV will be assessed in percentage. Possible correlations at a given timepoint will be explored (e.g. Spearman's Correlation).

Correlations between Perfused Boundary Region (PBR) and Perfused Vessel Density (PVD) measured sublinguallyDuring ICU stay, an average of 2 days after sepsis onset

Glycocalyx thickness will be measured with PBR (in μm) and PVD will be assessed in mm/mm\^2. Possible correlations at a given timepoint will be explored (e.g. Spearman's Correlation).

Correlations between Perfused Boundary Region (PBR) and Microvascular Flow Index (MFI) measured sublinguallyDuring ICU stay, an average of 2 days after sepsis onset

Glycocalyx thickness will be measured with PBR (in μm) and MFI will be assessed in points. Possible correlations at a given timepoint will be explored (e.g. Spearman's Correlation).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universitiy Hospital Muenster

🇩🇪

Muenster, Germany

Universitiy Hospital Muenster
🇩🇪Muenster, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.